RETATRUTIDE 30MG
Retatrutide 30mg dosage protocol is designed to support metabolic improvements and assist in weight management through once-weekly subcutaneous injections.
-Typical starting dose between 0.5 – 2 mg per week.
-Once-weekly injection schedule for ease of use.
-Gradual titration to manage side effects and improve tolerance.
-Reconstitute to a practical concentration for accurate dosing
-Store lyophilized in the freezer; reconstituted in the refrigerator
RETATRUTIDE 30MG
Dosing Protocol :
Suggested once-weekly injection approach for effective titration.
Weekly Dose: Start at 0.5 mg; gradually
increase as tolerated
Frequency:
Inject once per week subcutaneously
Cycle Length:
8–12 weeks (extend as needed for maintenance)
Maximum Dose:
Can escalate to 12 mg weekly, depending on goals
Timing:
Any time of day; consistency is key
Standard / Gradual Approach (3 mL = 10 mg/mL)
Phase Weekly Dose (mg)
Weeks 1–4: 0.5 mg 5 units
Weeks 5–8: 1 mg 10 units
Weeks 9–12: 2 mg 20 units
Weeks 13–16 (Optional): 4 mg 40 units
*Reconstitute with 3 mL of bacteriostatic water to create a 10 mg/mL solution. Note: 0.5 mg is just 5 units, below 10 units. Consider using smaller insulin syringes for better precision at very low doses.
For people who have used and tolerated you can just start at appropriate dosing.
MOTS-C 10MG
MOTS-C 10mg dosage protocol is a mitochondrial-derived peptide that may support metabolic regulation, exercise performance, and healthy aging through periodic subcutaneous injections.
-Common research use: 5 mg every 5 days or 10 mg per injection (advanced)
-Flexible dosing schedule (e.g., once every 5 days or 3x weekly)
-Reconstitute for accurate insulin syringe measurements (up to 3 mL max)
-Store lyophilized in the freezer; reconstituted in the refrigerator
Dosing Protocol:
Suggested approaches include a moderate “standard” schedule or an “advanced” higher dose regimen.
Standard Frequency:
Inject 5 mg once every 5 days (4 total injections over ~20 days)
Advanced Frequency:
Inject 10 mg up to 3 times weekly
Cycle Length:
Varies by research design (e.g., 4–8 weeks or longer).
Timing:
Subcutaneous administration; consistent injection timing suggested.
MOTS-C 10MG
Dosing Protocol:
Suggested approaches include a moderate “standard” schedule or an “advanced” higher dose regimen.
Standard Frequency:
Inject 5 mg once every 5 days (4 total injections over ~20 days)
Advanced Frequency:
Inject 10 mg up to 3 times weekly
Cycle Length:
Varies by research design (e.g., 4–8 weeks or longer).
Timing:
Subcutaneous administration; consistent injection timing suggested.
Standard / Gradual Approach (2 mL = 5 mg/mL)
Injection 1 (Day 1): 5 mg 100 units (1.0 mL)
Injection 2 (Day 6): 5 mg 100 units (1.0 mL)
Injection 3 (Day 11): 5 mg 100 units (1.0 mL)
Injection 4 (Day 16): 5 mg100 units (1.0 mL)
5-Amino-1MQ (10 mg Vial)
5-Amino-1MQ 10 mg dosage protocol supports metabolic research through once-daily subcutaneous or intramuscular micro-dosing.
-Typical starting dose 150 – 300 mcg per day
-Once-daily injection simplifies scheduling; optional split dosing for higher amounts
-Recommended reconstitution: 3 mL (≈ 3.33 mg/mL) for practical measurements
-Cycles of 8 – 12 weeks followed by a 2 – 4 week pause
-Store lyophilized vials frozen; refrigerate after reconstitution
5-Amino-1MQ (10 mg Vial)
Dosing Protocol Suggested once-daily injection schedule with optional escalation.
Daily Dose: Begin at 150 mcg; increase every 2 weeks as indicated
Frequency: Inject once daily; split dosing for > 0.5 mg if desired
Cycle Length: 8 – 12 weeks, followed by a 2 – 4 week break
Maximum Dose: Do not exceed 1 mg daily without professional oversight
Timing: Morning dosing preferred for consistency
Standard / Gradual Approach (3 mL = 3.33 mg/mL)
Weeks 1 – 2 150 mcg 5 units (0.05 mL)
Weeks 3 – 4 300 mcg 9 units (0.09 mL)
Weeks 5 – 8 450 mcg 14 units (0.14 mL)
Advanced / Aggressive Approach (2 mL = 5 mg/mL)
Weeks 1 – 4 :500 mcg (0.50 mg) 10 units (0.10 mL)
Weeks 5 – 8: 750 mcg (0.75 mg) 15 units (0.15 mL)
Weeks 9 – 12 (optional): 1 000 mcg (1.0 mg) 20 units (0.20 mL)
BPC 157 (10mg Vial)
BPC 157 10mg dosage protocol is often referenced for supporting tissue repair, aiding recovery from injuries, and potentially promoting gastrointestinal health through regular subcutaneous or intramuscular injections.
-Typical daily dose ranges from 300–500 mcg
-Often administered 1–2 times per day for 4–8 weeks
-Higher dosing protocols (500–750 mcg, 2–3x daily) are considered more “advanced”
-Reconstitute to achieve a practical injection volume (avoid extremely low syringe units)
-Store lyophilized in the freezer; reconstituted in the refrigerator
BPC 157 (10mg Vial)
Dosing Protocol Suggested daily injection approach based on common reference doses. Daily Dose:
Start around 300 mcg; gradually adjust as needed
Frequency:
1–2 injections per day (increasing frequency for advanced protocols)
Cycle Length:
Typically 4–8 weeks (some may extend up to 12 weeks)
Maximum Dose:
Up to ~750 mcg per injection, multiple times daily, per advanced references
Timing:
Space injections evenly; consistency is key
Standard / Gradual Approach (3 mL = ~3,333 mcg/mL)
Weeks 1–4: 300 mcg (1× daily) ~9 units
Weeks 5–8: 500 mcg (1× daily) ~15 units
Advanced / Aggressive Approach (2 mL = ~5,000 mcg/mL)
Weeks 1–4: 500 mcg (2× daily) ~10 units
Weeks 5–8: 750 mcg (2× daily) ~15 units
TB-500 (10mg Vial)
TB-500 10mg dosage protocol emphasizes tissue repair and injury management via subcutaneous injections in either a loading phase or ongoing maintenance regimen.
-Common weekly totals range from 2.5mg to 5mg, split into multiple injections
-Loading phases typically last 4–6 weeks before shifting to a maintenance schedule
-Reconstitute to a practical concentration (e.g., 2mL total) for accurate dosing
-Store lyophilized vials in the freezer; reconstituted at 2–8°C
-Subcutaneous administration is standard—rotate injection sites to minimize irritation
TB-500 (10mg Vial)
Dosing Protocol Suggestions for a loading phase followed by less frequent injections.
Loading (4–6 wks):
Up to 5 mg weekly, divided into 2 or more injections
Maintenance:
5 mg monthly or 2.5 mg bi-weekly, depending on goals
Advanced Daily Option:
0.5–0.7 mg/day (3–5 mg/week)
Frequency: Typically 2 injections/wk or daily micro doses
Injection Sites: Subcutaneous in fatty tissue
Standard / Gradual Approach (2 mL = 5 mg/mL)
Weeks 1–4 (Loading): 5 mg total per week (2.5 mg x 2) 50 units (0.5 mL) twice weekly
Weeks 5–6 (Optional): Continue 5 mg weekly if needed Same as above
Maintenance: 5 mg monthly (one injection) 100 units (1.0 mL)
Advanced / Aggressive Approach (2 mL Daily or High-Volume Weekly)
Daily (Optional): 500–700 mcg (0.5–0.7 mg) per day ~10–14 units (0.1–0.14 mL)
Weekly Aggregate: 3–5 mg total (split over the week) Varies by daily plan